Peptide & Compound Guide
At a glance
| Compound | Selank |
|---|---|
| Type | Synthetic peptide analogue |
| U.S. regulatory context | Not FDA approved in the United States |
| Evidence level | Limited human and preclinical research |
| Research area | Anxiety, stress and neurobiological research |
What is Selank?
Selank is a synthetic peptide discussed for anxiolytic and cognitive effects. Its evidence base is relatively small compared with established psychiatric treatments, and it is not FDA approved in the United States.
What does the research examine?
Research has explored neurochemical and behavioral effects, but broad claims about anxiety treatment, cognition or mood require stronger independent evidence.
What has not been established?
Mechanism, biomarker changes, animal findings and early clinical signals are not the same as proof that a compound safely improves meaningful health outcomes. Claims should be matched to the type, size and quality of evidence available.
Safety and regulatory context
People with anxiety, mood or other psychiatric symptoms should seek qualified clinical evaluation rather than self-treating with unapproved compounds.
Research sources
Use primary and authoritative sources when evaluating claims about this compound. Search results can change as new research is published.